Differential immunogenicity ofVibrio choleraeO139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide
Field testing of an inactivated bivalent O1/O139 cholera vaccine suggests thatVibrio choleraeO1 is more immunogenic thanV. choleraeO139. To investigate whether this might be partly attributable to the production of capsular polysaccharide (CPS) by O139 isolates, we have compared the immunogenicity o...
Gespeichert in:
Veröffentlicht in: | Vaccine 2009-02, Vol.27 (7), p.1055 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 7 |
container_start_page | 1055 |
container_title | Vaccine |
container_volume | 27 |
creator | Attridge, SR Wallerström, G Li, B-L Morona, R Holmgren, J |
description | Field testing of an inactivated bivalent O1/O139 cholera vaccine suggests thatVibrio choleraeO1 is more immunogenic thanV. choleraeO139. To investigate whether this might be partly attributable to the production of capsular polysaccharide (CPS) by O139 isolates, we have compared the immunogenicity of variant strains expressing different combinations of lipopolysaccharide (LPS) and CPS. These studies indicate that the core-linked LPS structure is of paramount importance for induction of antibodies to the serogroup antigen. By contrast CPS was minimally immunogenic. Significantly the presence of CPS did not modulate the immunogenicity of the underlying LPS. To examine whether differences in LPS structure might contribute to the differing immunogenicities of the O1 and O139 serogroups, an attempt was made to modify the normal O139 LPS structure by provision of one of several heterologouswzzgenes. The resulting variants displayed additional, atypical surface polysaccharide, whose modal length was characteristic for the particularwzzgene. By immunoblotting this novel material showed a ladder-like banding pattern typical of LPS, but its failure to be stained by silver indicated that it was not core-associated and was therefore more like truncated CPS. Consistent with our earlier findings, studies using systemic or mucosal routes of immunization failed to demonstrate any consistent enhancement of antibody responses associated with production of these aberrant polysaccharide polymers. |
doi_str_mv | 10.1016/j.vaccine.2008.11.101 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1618831303</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3476779571</sourcerecordid><originalsourceid>FETCH-proquest_journals_16188313033</originalsourceid><addsrcrecordid>eNqNj8tOwzAQRS0EEuXxCUiWWDd44rakax5i1w1C7CrXmSRTJXYY2xX5Ib4TF8Ge1YzmHp2rEeIGVAEKVnf74mCsJYdFqVRVABzPJ2IG1b2el0uoTsVMlavFfAHq_VxchLBXSi01rGfi65GaBhldJNNLGobkfIuOLMVJ-uaNdkxe2s73yAY3oNfyYJiMi0Hi58gYArlW1n8Waf2wI2cieReyQOY1sen7bLM2MR9p42pp4jSSzZ2N5-GHjB3KgOxb9mmUo--nkN_qcluNV-KsMX3A6995KW6fn14fXuYj-4-EIW73PrHL0RZWUFUatNL6f9Q3X31p2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1618831303</pqid></control><display><type>article</type><title>Differential immunogenicity ofVibrio choleraeO139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide</title><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Attridge, SR ; Wallerström, G ; Li, B-L ; Morona, R ; Holmgren, J</creator><creatorcontrib>Attridge, SR ; Wallerström, G ; Li, B-L ; Morona, R ; Holmgren, J</creatorcontrib><description>Field testing of an inactivated bivalent O1/O139 cholera vaccine suggests thatVibrio choleraeO1 is more immunogenic thanV. choleraeO139. To investigate whether this might be partly attributable to the production of capsular polysaccharide (CPS) by O139 isolates, we have compared the immunogenicity of variant strains expressing different combinations of lipopolysaccharide (LPS) and CPS. These studies indicate that the core-linked LPS structure is of paramount importance for induction of antibodies to the serogroup antigen. By contrast CPS was minimally immunogenic. Significantly the presence of CPS did not modulate the immunogenicity of the underlying LPS. To examine whether differences in LPS structure might contribute to the differing immunogenicities of the O1 and O139 serogroups, an attempt was made to modify the normal O139 LPS structure by provision of one of several heterologouswzzgenes. The resulting variants displayed additional, atypical surface polysaccharide, whose modal length was characteristic for the particularwzzgene. By immunoblotting this novel material showed a ladder-like banding pattern typical of LPS, but its failure to be stained by silver indicated that it was not core-associated and was therefore more like truncated CPS. Consistent with our earlier findings, studies using systemic or mucosal routes of immunization failed to demonstrate any consistent enhancement of antibody responses associated with production of these aberrant polysaccharide polymers.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2008.11.101</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><subject>Bacteriology ; Cholera ; Genes ; Immunization ; Immunogenicity ; Plasmids ; Polymers ; Vaccines ; Waterborne diseases</subject><ispartof>Vaccine, 2009-02, Vol.27 (7), p.1055</ispartof><rights>Copyright Elsevier Limited Feb 11, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1618831303?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,64385,64389,72469</link.rule.ids></links><search><creatorcontrib>Attridge, SR</creatorcontrib><creatorcontrib>Wallerström, G</creatorcontrib><creatorcontrib>Li, B-L</creatorcontrib><creatorcontrib>Morona, R</creatorcontrib><creatorcontrib>Holmgren, J</creatorcontrib><title>Differential immunogenicity ofVibrio choleraeO139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide</title><title>Vaccine</title><description>Field testing of an inactivated bivalent O1/O139 cholera vaccine suggests thatVibrio choleraeO1 is more immunogenic thanV. choleraeO139. To investigate whether this might be partly attributable to the production of capsular polysaccharide (CPS) by O139 isolates, we have compared the immunogenicity of variant strains expressing different combinations of lipopolysaccharide (LPS) and CPS. These studies indicate that the core-linked LPS structure is of paramount importance for induction of antibodies to the serogroup antigen. By contrast CPS was minimally immunogenic. Significantly the presence of CPS did not modulate the immunogenicity of the underlying LPS. To examine whether differences in LPS structure might contribute to the differing immunogenicities of the O1 and O139 serogroups, an attempt was made to modify the normal O139 LPS structure by provision of one of several heterologouswzzgenes. The resulting variants displayed additional, atypical surface polysaccharide, whose modal length was characteristic for the particularwzzgene. By immunoblotting this novel material showed a ladder-like banding pattern typical of LPS, but its failure to be stained by silver indicated that it was not core-associated and was therefore more like truncated CPS. Consistent with our earlier findings, studies using systemic or mucosal routes of immunization failed to demonstrate any consistent enhancement of antibody responses associated with production of these aberrant polysaccharide polymers.</description><subject>Bacteriology</subject><subject>Cholera</subject><subject>Genes</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Plasmids</subject><subject>Polymers</subject><subject>Vaccines</subject><subject>Waterborne diseases</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNj8tOwzAQRS0EEuXxCUiWWDd44rakax5i1w1C7CrXmSRTJXYY2xX5Ib4TF8Ge1YzmHp2rEeIGVAEKVnf74mCsJYdFqVRVABzPJ2IG1b2el0uoTsVMlavFfAHq_VxchLBXSi01rGfi65GaBhldJNNLGobkfIuOLMVJ-uaNdkxe2s73yAY3oNfyYJiMi0Hi58gYArlW1n8Waf2wI2cieReyQOY1sen7bLM2MR9p42pp4jSSzZ2N5-GHjB3KgOxb9mmUo--nkN_qcluNV-KsMX3A6995KW6fn14fXuYj-4-EIW73PrHL0RZWUFUatNL6f9Q3X31p2A</recordid><startdate>20090211</startdate><enddate>20090211</enddate><creator>Attridge, SR</creator><creator>Wallerström, G</creator><creator>Li, B-L</creator><creator>Morona, R</creator><creator>Holmgren, J</creator><general>Elsevier Limited</general><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20090211</creationdate><title>Differential immunogenicity ofVibrio choleraeO139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide</title><author>Attridge, SR ; Wallerström, G ; Li, B-L ; Morona, R ; Holmgren, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_16188313033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Bacteriology</topic><topic>Cholera</topic><topic>Genes</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Plasmids</topic><topic>Polymers</topic><topic>Vaccines</topic><topic>Waterborne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Attridge, SR</creatorcontrib><creatorcontrib>Wallerström, G</creatorcontrib><creatorcontrib>Li, B-L</creatorcontrib><creatorcontrib>Morona, R</creatorcontrib><creatorcontrib>Holmgren, J</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Attridge, SR</au><au>Wallerström, G</au><au>Li, B-L</au><au>Morona, R</au><au>Holmgren, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential immunogenicity ofVibrio choleraeO139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide</atitle><jtitle>Vaccine</jtitle><date>2009-02-11</date><risdate>2009</risdate><volume>27</volume><issue>7</issue><spage>1055</spage><pages>1055-</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Field testing of an inactivated bivalent O1/O139 cholera vaccine suggests thatVibrio choleraeO1 is more immunogenic thanV. choleraeO139. To investigate whether this might be partly attributable to the production of capsular polysaccharide (CPS) by O139 isolates, we have compared the immunogenicity of variant strains expressing different combinations of lipopolysaccharide (LPS) and CPS. These studies indicate that the core-linked LPS structure is of paramount importance for induction of antibodies to the serogroup antigen. By contrast CPS was minimally immunogenic. Significantly the presence of CPS did not modulate the immunogenicity of the underlying LPS. To examine whether differences in LPS structure might contribute to the differing immunogenicities of the O1 and O139 serogroups, an attempt was made to modify the normal O139 LPS structure by provision of one of several heterologouswzzgenes. The resulting variants displayed additional, atypical surface polysaccharide, whose modal length was characteristic for the particularwzzgene. By immunoblotting this novel material showed a ladder-like banding pattern typical of LPS, but its failure to be stained by silver indicated that it was not core-associated and was therefore more like truncated CPS. Consistent with our earlier findings, studies using systemic or mucosal routes of immunization failed to demonstrate any consistent enhancement of antibody responses associated with production of these aberrant polysaccharide polymers.</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1016/j.vaccine.2008.11.101</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2009-02, Vol.27 (7), p.1055 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_journals_1618831303 |
source | Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
subjects | Bacteriology Cholera Genes Immunization Immunogenicity Plasmids Polymers Vaccines Waterborne diseases |
title | Differential immunogenicity ofVibrio choleraeO139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A19%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20immunogenicity%20ofVibrio%20choleraeO139%20variants%20expressing%20different%20combinations%20of%20naturally%20occurring%20and%20atypical%20forms%20of%20the%20serogroup%20polysaccharide&rft.jtitle=Vaccine&rft.au=Attridge,%20SR&rft.date=2009-02-11&rft.volume=27&rft.issue=7&rft.spage=1055&rft.pages=1055-&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2008.11.101&rft_dat=%3Cproquest%3E3476779571%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1618831303&rft_id=info:pmid/&rfr_iscdi=true |